Fundz

Codis secures growth capital from 1315 Capital to expand its commercial manufacturing capacity in Haverhill, with support from BroadOak Capital Partners and RCT.

PRIVATEOct 16, 2025

Round Type

Funding Round

St. LouisManufacturingBiotechnologyPharmaceutical

Investors

BroadOak Capital PartnersResearch Corporation Technologies1315 Capital

Description

Codis, a CDMO focused on commercial spray drying, has announced a growth investment from 1315 Capital, joined by existing shareholders BroadOak Capital Partners and RCT. The funding will accelerate the expansion of Codis's manufacturing capabilities, particularly in Haverhill, UK. This investment is critical for supporting the increasing demand in the pharmaceutical industry for spray-drying expertise. Codis operates one of the largest commercial spray-drying platforms in the world.

Who else raised in Pharmaceutical and Manufacturing around the same time

Companies in the same sectors as Codis that raised within 45 days of this round, from Fundz verified event records.

  • Fennec Pharmaceuticals raised $35M (Post-IPO Equity) on November 17, 2025.
  • Scinai Immunotherapeutics Ltd raised $246K (Grant) on October 6, 2025.
  • Talphera, Inc. raised $17M on September 10, 2025.
  • Azora Therapeutics, Inc. (DE) raised $4.3M on November 28, 2025.
  • Hypershell raised $70M (Series B) on November 27, 2025.
  • SymPhysis Medical raised $1.3M (Grant) on November 26, 2025.

Who to call at Codis, and when

A new round usually means Codis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Codis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Codis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Codis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Codis

Location

St. Louis, Missouri, United States

About

Codis is a global CDMO specializing in commercial spray drying, amorphous solid dispersions, particle engineering, and finished dose manufacturing for the pharmaceutical, consumer health, nutraceutical, and OTC sectors. The company combines decades of regulatory expertise and manufacturing strength under one brand. With extensive manufacturing space and multiple GMP facilities, Codis is positioned to help pharmaceutical innovators accelerate therapies from development to market.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Codis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Codis's next move

See what Strategic adds

Codis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.